Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission

NCT00213083 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6203

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
AIDS
Sexually Transmitted Diseases
HIV Seroconversion

Interventions

DRUG: Carraguard (PC-515)

Sponsor

Population Council

Collaborators

[object Object]
[object Object]